Skip to Content

Geron admits timing of embryonic stem cell study to credit Obama

According to a Feb. 17, 2010 Times Online article, Dr. Thomas Okarma, CEO of Geron, admitted that Geron Corporation delayed asking for FDA approval for the first clinical trial using stem cells taken from human embryos in 2009. Okarma said their experiment to treat people with spinal cord injuries was delayed to give the Obama administration credit: "That was our timing. We did not want this to come up under the Bush Administration. We designed it."

 

After Cysts were discovered in animals given its stem-cell spinal injury therapy, clinical trials were delayed yet again. Read Times Online article.